[{"question": "Etanercept is a disease-modifying drug used in management of rheumatoid ahritis. What is its mechanism of action?", "correct_answer": "Inhibition of TNF alpha", "correct_idx": 0, "options": ["A)Inhibition of TNF alpha", "B)COX-2 inhibition", "C)IL-6 inhibition", "D)Stabilization of mast cells"], "prompt": "Etanercept is a disease-modifying drug used in management of rheumatoid ahritis. What is its mechanism of action?A)Inhibition of TNF alpha\nB)COX-2 inhibition\nC)IL-6 inhibition\nD)Stabilization of mast cells", "subject_name": "Pharmacology", "output0": "Etanercept is a tumor necrosis factor (TNF) inhibitor, which works by blocking the activity of TNF alpha, a cytokine that is involved in the inflammatory response. By inhibiting TNF alpha, etanercept can help to reduce the symptoms of rheumatoid arthritis, such as joint pain and swelling.\n\n", "output1": "Etanercept is a tumor necrosis factor (TNF) inhibitor, which works by blocking the activity of TNF alpha. This cytokine is involved in the inflammatory response and is overproduced in rheumatoid arthritis. By blocking TNF alpha, etanercept reduces the inflammation and joint damage associated with the disease.\n\n", "output2": "Etanercept is a tumor necrosis factor (TNF) inhibitor that blocks the activity of interleukin-6 (IL-6), a cytokine that is involved in the inflammatory response. By blocking the activity of IL-6, etanercept can help reduce inflammation and slow the progression of rheumatoid arthritis.\n\n", "output3": "Etanercept is a tumor necrosis factor (TNF) inhibitor, which works by blocking the action of TNF alpha, a cytokine that plays a key role in the inflammatory response. By blocking the action of TNF alpha, etanercept helps to reduce inflammation and slow down the progression of joint damage in patients with rheumatoid arthritis.\n\n"}, {"question": "Phase_____trial is used to signify the integration of a new clinical treatment into widespread public health practice?", "correct_answer": "Phase 5", "correct_idx": 3, "options": ["A)Phase 1", "B)Phase 2", "C)Phase 4", "D)Phase 5"], "prompt": "Phase_____trial is used to signify the integration of a new clinical treatment into widespread public health practice?A)Phase 1\nB)Phase 2\nC)Phase 4\nD)Phase 5", "subject_name": "Dental", "output0": "Phase 1 trials are used to assess the safety and feasibility of a new clinical treatment in a small number of participants. This phase is an initial step in the development of a new treatment and is often used to test the treatment in a controlled environment before it is introduced to the general public.\n\n", "output1": "Phase 2 clinical trials are used to evaluate the effectiveness and safety of a new clinical treatment in a larger and more diverse population of patients. This phase is typically used to assess the treatment's potential for widespread public health practice.\n\n", "output2": "Phase 4 trials are used to assess the effectiveness of a new clinical treatment in real-world settings, with a larger and more diverse population. This phase is often used to evaluate the practicality and feasibility of a new treatment in everyday practice, and to assess its impact on public health.\n\n", "output3": "Phase 5 trials are used to assess the effectiveness of a new clinical treatment in real-world settings, such as in clinical practice or in public health programs. This is the final phase of clinical trials before a treatment is considered for widespread use.\n\n"}, {"question": "Which is not related to HIV", "correct_answer": "Teiary syphilis", "correct_idx": 1, "options": ["A)Primary CNS lymphoma", "B)Teiary syphilis", "C)Oesophageal candidasis", "D)None"], "prompt": "Which is not related to HIVA)Primary CNS lymphoma\nB)Teiary syphilis\nC)Oesophageal candidasis\nD)None", "subject_name": "Medicine", "output0": "Primary CNS lymphoma is not related to HIV. The other options, teiary syphilis, oesophageal candidasis, are all related to HIV.\n\n", "output1": "Teiary syphilis is not related to HIV, it is a different condition caused by the bacterium Treponema pallidum.\n\n", "output2": "Oesophageal candidiasis is not related to HIV, as it is a condition caused by a fungal infection and not a viral infection like HIV.\n\n", "output3": "All of the options listed are related to HIV, except for oesophageal candidiasis. This condition is not related to HIV.\n\n"}, {"question": "Metamorphopsia is seen in ?", "correct_answer": "Posterior uveitis", "correct_idx": 1, "options": ["A)Anterior uveitis", "B)Posterior uveitis", "C)Cataract", "D)Glaucoma"], "prompt": "Metamorphopsia is seen in ?A)Anterior uveitis\nB)Posterior uveitis\nC)Cataract\nD)Glaucoma", "subject_name": "Ophthalmology", "output0": "Metamorphopsia is a condition where the patient perceives distorted or altered images, and it is commonly seen in anterior uveitis, which is inflammation of the iris and ciliary body. This condition can cause visual disturbances and may be associated with pain.\n\n", "output1": "Metamorphopsia is seen in posterior uveitis, which is a type of uveitis that affects the back of the eye. This condition can cause distorted vision, including the appearance of wavy lines or a \"metallic\" sheen, which is characteristic of metamorphopsia.\n\n", "output2": "Metamorphopsia is a visual phenomenon that occurs in patients with cataracts. It is characterized by the appearance of distorted images or shapes, and can be caused by changes in the lens of the eye that occur as a result of the cataract.\n\n", "output3": "Metamorphopsia is a visual disturbance that is commonly seen in glaucoma. It is characterized by distorted vision, such as seeing wavy or jagged lines, and can be an early sign of the disease.\n\n"}, {"question": "A 49-year-old woman presents to her pulmonologist for a follow-up visit. She reports a longstanding history of chronic dyspnea and fatigue. Her past medical history is notable for asthma. She has a known mutation in the BMPR2 gene. She was recently trialed on nifedipine but stopped due to severe lower extremity edema. She does not smoke and does not drink alcohol. Her temperature is 99.4\u00b0F (37.4\u00b0C), blood pressure is 135/80 mmHg, pulse is 80/min, and respirations are 20/min. Physical examination reveals an increased P2 on cardiac auscultation. Her physician recommends starting a medication to slow the patient\u2019s clinical worsening that requires regular monitoring of liver function tests. This medication has which of the following mechanisms of action?", "correct_answer": "Endothelin-1 receptor antagonist", "correct_idx": 0, "options": ["A)Endothelin-1 receptor antagonist", "B)Beta-2-adrenergic receptor agonist", "C)Phospholipase A2 antagonist", "D)Phosphodiesterase type 5 antagonist"], "prompt": "A 49-year-old woman presents to her pulmonologist for a follow-up visit. She reports a longstanding history of chronic dyspnea and fatigue. Her past medical history is notable for asthma. She has a known mutation in the BMPR2 gene. She was recently trialed on nifedipine but stopped due to severe lower extremity edema. She does not smoke and does not drink alcohol. Her temperature is 99.4\u00b0F (37.4\u00b0C), blood pressure is 135/80 mmHg, pulse is 80/min, and respirations are 20/min. Physical examination reveals an increased P2 on cardiac auscultation. Her physician recommends starting a medication to slow the patient\u2019s clinical worsening that requires regular monitoring of liver function tests. This medication has which of the following mechanisms of action?A)Endothelin-1 receptor antagonist\nB)Beta-2-adrenergic receptor agonist\nC)Phospholipase A2 antagonist\nD)Phosphodiesterase type 5 antagonist", "subject_name": null, "output0": "The correct answer is A)Endothelin-1 receptor antagonist because the patient has a known mutation in the BMPR2 gene. This gene encodes a receptor for endothelin-1, a potent vasoconstrictor peptide. Endothelin-1 receptor antagonists have been shown to improve exercise capacity and reduce symptoms in patients with pulmonary arterial hypertension associated with BMPR2 mutations.\n\n", "output1": "The correct answer is B)Beta-2-adrenergic receptor agonist. This medication has the mechanism of action of increasing beta-2 adrenergic receptor activity, which can help to slow the clinical worsening of the patient\u2019s condition.\n\n", "output2": "The correct answer is C)Phospholipase A2 antagonist because the medication being described is a statin, which is a type of cholesterol-lowering medication that works by inhibiting the activity of phospholipase A2, an enzyme involved in cholesterol synthesis. Statins are commonly used to treat dyslipidemia and have been shown to slow the progression of pulmonary arterial hypertension.\n\n", "output3": "The medication recommended by the physician is a phosphodiesterase type 5 (PDE5) inhibitor. This type of medication works by blocking the action of PDE5, an enzyme that breaks down cyclic guanosine monophosphate (cGMP), a molecule that plays a key role in smooth muscle relaxation. By blocking the action of PDE5, the medication allows for higher levels of cGMP in the body, leading to increased relaxation of smooth muscle and improved lung function. This mechanism of action is particularly useful in patients with pulmonary hypertension.\n\n"}, {"question": "Prolactin secreted maximum at-", "correct_answer": "24 hrs after delivery", "correct_idx": 0, "options": ["A)24 hrs after delivery", "B)REM", "C)2 hrs running", "D)24 hour after Ovulation"], "prompt": "Prolactin secreted maximum at-A)24 hrs after delivery\nB)REM\nC)2 hrs running\nD)24 hour after Ovulation", "subject_name": "Gynaecology & Obstetrics", "output0": "Prolactin levels are highest immediately after birth and remain elevated for the first few days of life. This is due to the hormonal changes that occur during pregnancy and childbirth. Prolactin plays a role in the initiation of lactation and the establishment of breastfeeding.\n\n", "output1": "Prolactin secretion is highest during REM sleep, which occurs during the deep sleep stage of the sleep cycle. This is why prolactin levels are typically highest in the morning, after a night of sleep.\n\n", "output2": "Prolactin is a hormone that is secreted by the pituitary gland in response to physical activity. The maximum level of prolactin secretion occurs 2 hours after the onset of exercise, which is why the correct answer is C)2 hrs running.\n\n", "output3": "Prolactin is a hormone that is secreted by the pituitary gland and plays a role in lactation and milk production. The highest levels of prolactin are typically seen 24 hours after ovulation, which is when the body is preparing for pregnancy.\n\n"}, {"question": "Statements about hostility (hostility) and coronary heart disease, which of the following error?", "correct_answer": "Hostility promotes parasympathetic function", "correct_idx": 2, "options": ["A)According to patterns of behavior theory, A-type behavior (type A behavior) represents irritability, impatience, impatient, associated with the incidence of myocardial infarction and coronary heart disease", "B)Hostility is the core component of type A behavior", "C)Hostility promotes parasympathetic function", "D)Myocardial infarction patients were group psychotherapy to improve their Type A behavior, can effectively reduce mortality and reinfarction rate"], "prompt": "Statements about hostility (hostility) and coronary heart disease, which of the following error?A)According to patterns of behavior theory, A-type behavior (type A behavior) represents irritability, impatience, impatient, associated with the incidence of myocardial infarction and coronary heart disease\nB)Hostility is the core component of type A behavior\nC)Hostility promotes parasympathetic function\nD)Myocardial infarction patients were group psychotherapy to improve their Type A behavior, can effectively reduce mortality and reinfarction rate", "subject_name": null, "output0": "The statement A-type behavior (type A behavior) represents irritability, impatience, impatient, associated with the incidence of myocardial infarction and coronary heart disease is incorrect. According to the patterns of behavior theory, type A behavior is characterized by competitiveness, aggressiveness, and a sense of time urgency, but not necessarily by irritability or hostility.\n\n", "output1": "Hostility is not a core component of type A behavior, according to patterns of behavior theory. Instead, type A behavior is characterized by traits such as competitiveness, aggressiveness, and impatience.\n\n", "output2": "The statement C)Hostility promotes parasympathetic function is incorrect. Hostility is not directly related to parasympathetic function, but rather to the sympathetic nervous system, which can increase heart rate and blood pressure.\n\n", "output3": "The correct answer is D)Myocardial infarction patients were group psychotherapy to improve their Type A behavior, can effectively reduce mortality and reinfarction rate. This is incorrect because it is not based on the patterns of behavior theory, which suggests that hostility is a core component of type A behavior, and that type A behavior is associated with an increased risk of myocardial infarction and coronary heart disease.\n\n"}, {"question": "A dental disturbance that has a greater psychological impact on both the parents and child is", "correct_answer": "Fracture or loss of an anterior tooth", "correct_idx": 2, "options": ["A)Multiple decayed teeth", "B)Discolored front tooth", "C)Fracture or loss of an anterior tooth", "D)Mucocele"], "prompt": "A dental disturbance that has a greater psychological impact on both the parents and child isA)Multiple decayed teeth\nB)Discolored front tooth\nC)Fracture or loss of an anterior tooth\nD)Mucocele", "subject_name": "Dental", "output0": "Multiple decayed teeth can have a significant psychological impact on both the parents and child, as it can lead to feelings of embarrassment, shame, and low self-esteem. Additionally, the financial burden of treating multiple decayed teeth can cause significant stress and anxiety for parents.\n\n", "output1": "The discoloration of a front tooth can have a greater psychological impact on both parents and child due to the prominence of the front teeth in the smile and the importance of appearance and self-esteem in childhood.\n\n", "output2": "The loss of an anterior tooth, especially one that is prominent or visible, can have a greater psychological impact on both the parents and child due to the aesthetic and functional implications. This can affect the child's self-esteem, confidence, and ability to eat and speak properly.\n\n", "output3": "Mucocele is a dental disturbance that can have a greater psychological impact on both the parents and child compared to other dental issues. This is because it is a relatively rare condition that can cause anxiety and self-consciousness in children, particularly if it is visible or prominent. Additionally, the treatment process for mucocele can be more complex and time-consuming, which can add to the stress and emotional impact on the child and their family.\n\n"}, {"question": "True about oral iron preparations ?", "correct_answer": "Different preparations have different biovailability", "correct_idx": 2, "options": ["A)Most commonly used preparation is ferrous gluconate", "B)Ferrous fumarate is most efficient", "C)Different preparations have different biovailability", "D)Ferric preparations are more effective"], "prompt": "True about oral iron preparations ?A)Most commonly used preparation is ferrous gluconate\nB)Ferrous fumarate is most efficient\nC)Different preparations have different biovailability\nD)Ferric preparations are more effective", "subject_name": "Pharmacology", "output0": "Oral iron preparations are most commonly used preparation is ferrous gluconate because it is well-tolerated and has good bioavailability. It is also less likely to cause gastrointestinal side effects compared to other preparations like ferrous sulfate.\n\n", "output1": "Ferrous fumarate is the most efficient oral iron preparation because it has the highest bioavailability compared to other iron preparations. This means that it is more easily absorbed by the body and can provide a more effective dose of iron.\n\n", "output2": "Oral iron preparations have different bioavailability, meaning that the body can absorb different amounts of iron from different preparations. Ferrous gluconate and ferrous fumarate are two common iron preparations, but they have different bioavailability. Ferrous gluconate has a higher bioavailability than ferrous fumarate.\n\n", "output3": "Ferric preparations, such as ferrous sulfate, are more effective than ferrous gluconate or ferrous fumarate because they are more easily absorbed by the body. Additionally, ferric preparations are less likely to cause gastrointestinal side effects, such as nausea and diarrhea, which can be a problem with some oral iron preparations.\n\n"}, {"question": "Under ESI act, the state government's share of expenditure on medical care is?", "correct_answer": "1/8th", "correct_idx": 2, "options": ["A)1/4th", "B)2/3rd", "C)1/8th", "D)2-Jan"], "prompt": "Under ESI act, the state government's share of expenditure on medical care is?A)1/4th\nB)2/3rd\nC)1/8th\nD)2-Jan", "subject_name": "Dental", "output0": "The ESI Act provides that the state government's share of expenditure on medical care shall be 1/4th of the total expenditure.\n\n", "output1": "Under the ESI Act, the state government's share of expenditure on medical care is 2/3rd. This is because the Act provides for a 2/3rd share of the expenditure on medical care to be borne by the state government, while the remaining 1/3rd is to be borne by the employer.\n\n", "output2": "The state government's share of expenditure on medical care under the ESI Act is 1/8th. This is because the Act provides for a shared funding mechanism between the central and state governments, with the central government contributing 1/4th of the total expenditure and the state governments contributing 1/8th.\n\n", "output3": "Under the ESI Act, the state government's share of expenditure on medical care is 2-Jan, which means that the state government bears 2/3rd of the expenditure on medical care, while the remaining 1/3rd is borne by the employer and the employee.\n\n"}]